Nancy Lurker

Insider Reports History

Location
Dublin 4
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Lurker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Director Common Stock 207K $3.12M $15.11 04 Dec 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Common Stock 127K $1.52M $11.99 04 Dec 2025 By Family Trust
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 22.5K $603K $26.78 15 May 2025 Direct
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 31 May 2024 Direct
Alkermes plc. Director Ordinary Shares 10.7K $328K $30.61 31 May 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Restricted Stock Units 11.1K $0 $6.50 10 Jul 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 49.7K 02 Jul 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 27.3K 02 Jul 2025 By Family Trust
Aquestive Therapeutics, Inc. Director Stock Option (Right to Purchase) 20K 15 Jun 2021 Direct
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 13.5K 21 May 2025 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 31 May 2025 Direct

Insider Reports Filed by Nancy Lurker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYPT EyePoint Pharmaceuticals, Inc. 04 Dec 2025 1 -$140K 4 Director 05 Dec 2025, 16:06
EYPT EyePoint Pharmaceuticals, Inc. 26 Nov 2025 2 -$10.5K 4 Director 01 Dec 2025, 16:09
EYPT EyePoint Pharmaceuticals, Inc. 10 Jul 2025 2 $0 4 Director 11 Jul 2025, 16:06
EYPT EyePoint Pharmaceuticals, Inc. 02 Jul 2025 10 $0 4 Director 02 Jul 2025, 16:05
ALKS Alkermes plc. 31 May 2025 3 -$58.9K 4 Director 02 Jun 2025, 16:31
ALKS Alkermes plc. 21 May 2025 2 $0 4 Director 23 May 2025, 17:58
COLL COLLEGIUM PHARMACEUTICAL, INC 15 May 2025 1 $0 4 Director 19 May 2025, 17:43
ALKS Alkermes plc. 11 Apr 2025 6 -$39.4K 4 Director 14 Apr 2025, 17:17
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2025 2 $0 4 Director 11 Feb 2025, 18:19
COLL COLLEGIUM PHARMACEUTICAL, INC 04 Feb 2025 1 $0 4 Director 05 Feb 2025, 17:30
COLL COLLEGIUM PHARMACEUTICAL, INC 04 Feb 2025 0 $0 3 Director 05 Feb 2025, 17:30
EYPT EyePoint Pharmaceuticals, Inc. 03 Jan 2025 5 $0 4 Director 07 Jan 2025, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 16 Aug 2024 1 $25K 4 Director 20 Aug 2024, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 26 Jul 2024 10 $0 4 Director 26 Jul 2024, 16:47
EYPT EyePoint Pharmaceuticals, Inc. 10 Jul 2024 2 $0 4 Executive Vice Chair, Director 12 Jul 2024, 17:03
ALKS Alkermes plc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:56
ALKS Alkermes plc. 11 Apr 2024 4 $0 4 Director 12 Apr 2024, 16:16
ALKS Alkermes plc. 05 Mar 2024 0 $0 3 Director 15 Mar 2024, 16:13
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2024 14 -$430K 4 Executive Vice Chair, Director 13 Feb 2024, 17:40
EYPT EyePoint Pharmaceuticals, Inc. 23 Jan 2024 4 -$874K 4 Executive Vice Chair, Director 25 Jan 2024, 18:24
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 5 -$470K 4 Executive Vice Chair, Director 09 Jan 2024, 21:17
EYPT EyePoint Pharmaceuticals, Inc. 28 Dec 2023 8 $0 4/A Executive Vice Chair, Director 03 Jan 2024, 18:37
EYPT EyePoint Pharmaceuticals, Inc. 28 Dec 2023 6 $0 4 Executive Vice Chair, Director 02 Jan 2024, 17:41
EYPT EyePoint Pharmaceuticals, Inc. 04 Dec 2023 1 -$415K 4 Executive Vice Chair, Director 06 Dec 2023, 17:18
EYPT EyePoint Pharmaceuticals, Inc. 10 Jul 2023 2 $0 4 Executive Vice Chair, Director 12 Jul 2023, 18:52
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 1 $0 4 CEO, Director 22 Jun 2023, 09:14
EYPT EyePoint Pharmaceuticals, Inc. 11 May 2023 14 $0 4 CEO, Director 15 May 2023, 18:15
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2023 4 $0 4 CEO, Director 13 Feb 2023, 15:56
EYPT EyePoint Pharmaceuticals, Inc. 06 Jan 2023 1 $0 4 CEO, Director 10 Jan 2023, 16:58
EYPT EyePoint Pharmaceuticals, Inc. 28 Feb 2022 2 $0 4 President & CEO, Director 02 Mar 2022, 17:21
EYPT EyePoint Pharmaceuticals, Inc. 21 Feb 2022 2 $0 4 President & CEO, Director 23 Feb 2022, 15:13
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2022 4 $0 4 President & CEO, Director 11 Feb 2022, 15:38
EYPT EyePoint Pharmaceuticals, Inc. 15 Nov 2021 1 -$201K 4 President & CEO, Director 17 Nov 2021, 16:03
EYPT EyePoint Pharmaceuticals, Inc. 22 Jun 2021 2 $0 4 President & CEO, Director 23 Jun 2021, 17:27
AQST Aquestive Therapeutics, Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 18:51
EYPT EyePoint Pharmaceuticals, Inc. 14 Jun 2021 2 $0 4 President & CEO, Director 15 Jun 2021, 17:04